Showing 28,621 - 28,640 results of 28,937 for search '"Gastroenterology"', query time: 0.21s Refine Results
  1. 28621
  2. 28622
  3. 28623
  4. 28624
  5. 28625
  6. 28626
  7. 28627
  8. 28628
  9. 28629
  10. 28630
  11. 28631
  12. 28632
  13. 28633

    Use of probiotics in treating psychiatric and neurological disorders by Saiyeda Maha Fatima, Areeb Khan, Bushra Asghar

    Published 2023-12-01
    “…As the relationship between psychiatric and gastrointestinal symptoms becomes well-established with 60% of patients with gastroenterological complaints having psychiatric origins [3], the question arises of whether it would be beneficial to focus on the gut microbiota and use probiotics to treat psychiatric and neurological ailments. …”
    Get full text
    Article
  14. 28634

    Nomogram Based on Preoperative Fibrinogen and Systemic Immune-Inflammation Index Predicting Recurrence and Prognosis of Patients with Borrmann Type III Advanced Gastric Cancer by Wang H, Yin X, Ma K, Wang Y, Fang T, Zhang Y, Xue Y

    Published 2023-03-01
    “…Hao Wang,1,* Xin Yin,1,* Keru Ma,2,* Yufei Wang,1,* Tianyi Fang,1 Yao Zhang,1 Yingwei Xue1 1Department of Gastroenterological Surgery, Harbin Medical University Cancer Hospital, Harbin, People’s Republic of China; 2Department of Thoracic Surgery, Esophagus and Mediastinum, Harbin Medical University Cancer Hospital, Harbin, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yingwei Xue, Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, 150081, People’s Republic of China, Tel +86-13304646901, Email xueyingwei@hrbmu.edu.cnBackground and Objectives: The prognosis is known to differ significantly among advanced gastric cancer (AGC) with Borrmann type III. …”
    Get full text
    Article
  15. 28635

    Protective Effects of ACE/NEP Dual Inhibitor Omapatrilat for Indomethacin-induced Gastric Ulcer by Kadir Giray ERKAYMAN, Rüstem Anıl UĞAN, Zeynep Berna AKSAKALLI MAĞDEN, Eda YILMAZ, Ayşe BOZKURT, Elif ÇADIRCI

    Published 2023-12-01
    “…Aim: The renin-angiotensin-aldosterone system (RAAS) plays important roles in oxidative stress and various gastroenterological mechanisms. Omapatrilat, an RAAS-acting agent, inhibits both neprilysin neutral endopeptidase (NEP) and angiotensin converting enzyme (ACE) and may therefore affect protective mechanisms against gastric ulcer. …”
    Get full text
    Article
  16. 28636

    Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort. by Shou-Chien Hsu, Shy-Shin Chang, Meng-Tse Gabriel Lee, Si-Huei Lee, Yi-Wen Tsai, Shen-Che Lin, Szu-Ta Chen, Yi-Chieh Weng, Lorenzo Porta, Jiunn-Yih Wu, Chien-Chang Lee

    Published 2017-01-01
    “…Fluoroquinolone is a commonly prescribed antimicrobial agent, and up to 20% of its users registers adverse gastroenterological symptoms. We aimed to evaluate the association between use of fluoroquinolone and gastrointestinal tract perforation.We conducted a nested case-control study on a national health insurance claims database between 1998 and 2011. …”
    Get full text
    Article
  17. 28637

    Gastric Cancer in History: A Perspective Interdisciplinary Study by Skender Topi, Luigi Santacroce, Lucrezia Bottalico, Andrea Ballini, Alessio Danilo Inchingolo, Gianna Dipalma, Ioannis Alexandros Charitos, Francesco Inchingolo

    Published 2020-01-01
    “…We examined the historical evolving knowledge of the disease along the centuries on the gastroenterological, pharmacological, and surgical fields, defining how gastric cancer became an increasingly curable disease. …”
    Get full text
    Article
  18. 28638

    Clinical features and food preferences in persons with irritable bowel syndrome against the background of overweight and obesity by Maksim M. Fedorin, Maria A. Livzan, Olga V. Gaus

    Published 2022-07-01
    “…Assessment of other gastroenterological complaints was carried out using a 4-point scale. …”
    Get full text
    Article
  19. 28639
  20. 28640